← Back to Clinical Trials
Recruiting NCT07336017

NCT07336017 Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07336017
Status Recruiting
Phase
Sponsor University Hospital, Strasbourg, France
Condition Anal Incontinence
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-06-17
Primary Completion 2026-12

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2025-06-17 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Obstetric anal sphincter injuries are a source of significant short-term (pain, bleeding, infection, suture dehiscence), medium-term (anorectovaginal fistulas, sexual dysfunction), and long-term (anal incontinence in 30-60% of cases) morbidity. However, they are underdiagnosed and sometimes poorly repaired due to technical difficulties, the use of inappropriate surgical techniques, or a lack of awareness of their significant long-term morbidity. These diagnostic and therapeutic errors, however, significantly worsen the functional prognosis of patients. This study aims to evaluate the clinical impact of an educational program designed for continuing education in the diagnosis and repair of obstetric anal sphincter injuries for staff working in the delivery room.

Eligibility Criteria

Inclusion Criteria: * Adult women (≥18 years old) * who gave birth vaginally at Strasbourg University Hospital in the 3 months prior to and 3 months following the training of delivery room staff at both maternity wards * Singleton pregnancy * Live birth Exclusion Criteria: * Multiple pregnancy * Fetal death in utero * Medical termination of pregnancy * Delivery by cesarean section.

Contact & Investigator

Central Contact

Lise LECOINTRE, MD

✉ lise.lecointre@chu-strasbourg.fr

📞 33 3 88 12 74 7

Frequently Asked Questions

Who can join the NCT07336017 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Anal Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07336017 currently recruiting?

Yes, NCT07336017 is actively recruiting participants. Contact the research team at lise.lecointre@chu-strasbourg.fr for enrollment information.

Where is the NCT07336017 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07336017 clinical trial?

NCT07336017 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology